On February 6, 2024, the company announced an increase in its equity buyback plan. The company increased its authorization by $50 million, thereby bringing total authorization to $100 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.77 CNY | -1.67% | -3.29% | -5.54% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.54% | 375M | |
+11.98% | 9.08B | |
-12.85% | 5.06B | |
+54.35% | 4.85B | |
+1.60% | 3.85B | |
+14.09% | 2.37B | |
-20.85% | 2.36B | |
+25.03% | 2.27B | |
-30.36% | 2.22B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Guiyang Xintian Pharmaceutical Co.,Ltd. announces an Increase in Equity Buyback.